SimonMed, a large U.S.-based outpatient imaging provider, has announced the expansion of its artificial intelligence (AI)-enabled imaging platform across its national network, integrating U.S. FDA-cleared technologies into routine diagnostic workflows.
Comparable Canadian organisations include Canada Diagnostic Centres, Insight Medical Imaging, and Shared Health, where AI-assisted diagnostics and AI-enabled workflow optimisation are likewise progressing, albeit at a more measured pace.
The development reflects a broader shift within radiology from episodic, diagnostic imaging toward a more continuous, data-driven model that supports preventive care and risk stratification. SimonMed represents a commercial, technology-forward model of imaging as a scalable service, while Canadian providers operate within a public health framework prioritising equity, governance, and clinical necessity.
The expanded platform applies AI algorithms to standard imaging studies already performed in clinical practice, enabling the extraction of additional quantitative and diagnostic information without requiring further scan time or exposing patients to additional radiation. This approach aligns with growing interest in “opportunistic screening,” whereby existing imaging datasets are leveraged to identify subclinical disease.
Three principal AI-enhanced applications are included in the rollout: Calcium Score+, CT Bone Density, and MR Lumbar Spine+.
AI-Augmented Cardiovascular and Skeletal Risk Assessment
Calcium Score+ builds upon conventional coronary artery calcium (CAC) scoring by applying AI-driven image analysis to enhance the detection and quantification of calcified plaque within the coronary arteries. CAC scoring is a well-established predictor of cardiovascular risk, particularly for stratifying asymptomatic individuals. The integration of AI may improve consistency of measurement and provide more structured reporting, potentially supporting earlier identification of patients at elevated risk of atherosclerotic disease.
CT Bone Density represents an opportunistic screening tool for skeletal health. Using AI-based analysis of CT images that include the spine—such as chest, abdomen, or pelvis scans—the system estimates bone mineral density without requiring a dedicated dual-energy X-ray absorptiometry (DEXA) examination. This approach may facilitate earlier identification of osteopenia and osteoporosis, particularly in patients who might not otherwise undergo formal screening.
Both Calcium Score+ and CT Bone Density can be integrated into non-contrast CT chest examinations, including lung cancer screening programmes. CT Bone Density is also applicable to abdominal and pelvic CT imaging, thereby extending the potential screening population. Clinically, these developments are significant because both cardiovascular disease and osteoporosis often remain asymptomatic until advanced stages, and earlier detection offers opportunities for intervention to reduce morbidity and mortality.
AI-Enhanced Musculoskeletal Imaging
MR Lumbar Spine+ extends the application of AI to magnetic resonance imaging (MRI), enabling automated quantification and grading of degenerative spinal changes. The system provides structured outputs, including severity grading and annotated visualisations, designed to support both radiological interpretation and referring clinician decision-making.
Standard lumbar spine MRI interpretation can be subject to interobserver variability, particularly in grading features such as disc degeneration or spinal canal stenosis. AI-assisted quantification has the potential to improve reproducibility and objectivity, although clinical validation and integration into established diagnostic pathways remain important considerations.
Integration into Clinical Workflow and Patient Engagement
A key feature of the AI platforms is its integration into routine clinical workflows within community-based imaging centres, as opposed to being limited to academic or specialist institutions. This may facilitate broader access to advanced imaging analytics, particularly in outpatient settings where the volume of imaging studies is high.
In addition to clinician-facing outputs, the platform includes a patient-facing digital interface. Results are delivered through a mobile-based system that translates imaging findings into simplified summaries, accompanied by visual explanations and suggested next steps. Patients are also provided access to care navigation services for follow-up.
While patient engagement tools may improve understanding and adherence, they also raise considerations around health literacy, interpretation of risk information, and the potential for patient anxiety—particularly when subclinical findings are identified. As such, appropriate clinical context and follow-up pathways are essential.
Implications for Preventive Medicine
The integration of AI into routine imaging reflects a broader conceptual shift in radiology. Traditionally, imaging has been used to confirm or exclude suspected pathology. Increasingly, however, there is interest in using imaging as a source of longitudinal health data, enabling earlier identification of risk and more personalised approaches to prevention.
This model aligns with wider trends in healthcare, including precision medicine and population-level screening strategies. Opportunistic use of imaging data may be particularly valuable in identifying conditions with a long asymptomatic phase, such as coronary artery disease or osteoporosis.
However, the expansion of such capabilities also raises important clinical and operational questions. These include the management of incidental findings, the potential for overdiagnosis, and the need for evidence demonstrating improved outcomes associated with AI-driven screening approaches. Cost-effectiveness and integration with existing clinical guidelines will also be key factors influencing adoption.